Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.100
+0.279 (33.90%)
At close: Nov 20, 2024, 4:00 PM
0.971
-0.129 (-11.75%)
Pre-market: Nov 21, 2024, 5:49 AM EST

Coherus BioSciences Market Cap

Coherus BioSciences has a market cap or net worth of $126.73 million as of November 21, 2024. Its market cap has decreased by -53.93% in one year.

Market Cap
126.73M
Enterprise Value
298.92M
1-Year Change
-53.93%
Ranking
Category
Stock Price
$1.10

Market Cap Chart

Since November 6, 2014, Coherus BioSciences's market cap has decreased from $404.20M to $126.73M, a decrease of -68.65%. That is a compound annual growth rate of -10.90%.

History

DateMarket Cap% Change
Nov 20, 2024126.70M-65.83%
Dec 29, 2023370.80M-39.81%
Dec 30, 2022616.00M-49.73%
Dec 31, 20211.23B-2.13%
Dec 31, 20201.25B-0.83%
Dec 31, 20191.26B105.12%
Dec 31, 2018615.60M20.73%
Dec 29, 2017509.90M-58.50%
Dec 30, 20161.23B37.60%
Dec 31, 2015893.00M64.52%
Dec 31, 2014542.80M34.29%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Zomedica 128.57M
Adverum Biotechnologies 128.35M
Compugen 128.04M
Zentek 127.35M
Fennec Pharmaceuticals 127.29M
Outlook Therapeutics 124.90M
Telomir Pharmaceuticals 124.36M
Protalix BioTherapeutics 124.29M
Market Cap Rankings